Adagene Inc.

NASDAQ: ADAG
Share price (4/25/25): $1.42
Market cap (4/25/25): $83.6 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 12/31/23 FY 2023

ended 12/31/22 FY 2022

ended 12/31/21 FY 2021

ended 12/31/20 FY 2020

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Shelf registration – amended

Shelf registration – amended

Delaying amendment

Shelf registration

Ownership Filter

Panacea Innovation Ltd

Smith Vincent C

OT Healthcare Fund I, LLC

News Filter

Reports Full Year 2024 Financial Results and Provides Corporate Update

Announces Updated Data From Phase 1b/2 Study of Muzastotug in Combination With KEYTRUDA® (Pembrolizumab) in Colorectal Cancer at ASCO Gastrointestinal Cancers Symposium

Material disclosure – amended

Material disclosure – amended

- Improved Safety and Efficacy Profiles for ADG126 Versus Ipilimumab Driven by Precision Masking, Novel Epitope-Dependent Antibody-Dependent Cellular Cytotoxicity (ADCC) and Partial CTLA-4 Blockade

Proxies

No filings in this category.

Other Filter

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness